● Live Tracking 375+ pre-IPO companies with institutional-grade data โ€” updated daily. 140 in active pipeline.

Viz.ai IPO Status 2026

AI-powered clinical decision support platform that detects time-sensitive conditions and coordinates care teams.

IndustryHealthcare Technology
StageSeries E
IPO StatusPre-IPO
Valuation$1.2B
Total Funding$310M
HeadquartersSan Francisco, CA
CEOChris Mansi
How to Invest in Viz.ai
Pre-IPO
๐Ÿ”” Get Notified When Viz.ai IPOs

No secondary market access for Viz.ai yet. Get instant alerts when an S-1 is filed or IPO date is announced.

Get IPO Alerts โ†’
๐Ÿ“ก IPO Intelligence
$49/mo โ€” Unlimited Reports + Real-Time Updates
โšกUnlimited company analysis reports โ€” all 375+ companies
โœ“Real-time IPO alerts โ€” know the moment S-1s are filed
โœ“Verified data updated daily โ€” not chatbot hallucinations
๐Ÿ’ก Tracking multiple companies? Full access pays for itself after 3 reports.
$49
per month
Subscribe Now โ†’
Cancel anytime ยท Secure via Stripe
Institutional Research
$19 โ€” Get the Complete Viz.ai Analysis Brief
โœ“Executive summary & IPO readiness breakdown
โœ“Competitive positioning & funding trajectory
โœ“Bull / bear thesis with pricing projections
โœ“S-1 timeline estimate & risk assessment
$19
One-time
Secure checkout ยท Stripe ยท 24h delivery

Frequently Asked Questions

What is Viz.ai's current valuation? +

Viz.ai is valued at $1.2B as of June 2022.

Has Viz.ai filed for an IPO? +

Viz.ai is currently classified as pre-IPO. No S-1 has been publicly filed. Monitor TechStackIPO for the latest IPO status updates.

How much total funding has Viz.ai raised? +

Viz.ai has raised $310M in total venture capital funding.

What sector is Viz.ai in? +

Viz.ai is a Healthcare Technology company. AI-powered clinical decision support platform that detects time-sensitive conditions and coordinates.

What is Viz.ai's IPO readiness score? +

Viz.ai scores 70/100 on TechStackIPO's IPO readiness index, which evaluates funding stage, valuation trajectory, S-1 filing status, and market timing signals.